Trial · NCT02408315
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Delivery | Buccal Misoprostol/Vaginal Placebo | 28.1 | 95% Confidence Interval 24.1 to 31.4 | hours | |
| Time to Delivery | Vaginal Misoprostol/Buccal Placebo | 20.1 | 95% Confidence Interval 18.2 to 22.8 | hours | |
| Number of Participants With Cesarean Deliveries Based on Fetal Non-Reassurance Indications | Buccal Misoprostol/Vaginal Placebo | 14 | Participants | ||
| Number of Participants With Cesarean Deliveries Based on Fetal Non-Reassurance Indications | Vaginal Misoprostol/Buccal Placebo | 5 | Participants | ||
| Number of Vaginal Deliveries That Occurred Within 24 Hours | Buccal Misoprostol/Vaginal Placebo | 58 | Participants | ||
| Number of Vaginal Deliveries That Occurred Within 24 Hours | Vaginal Misoprostol/Buccal Placebo | 89 | Participants | ||
| Number of Participants Who Had Uterine Hyperstimulation | Buccal Misoprostol/Vaginal Placebo | 18 | Participants | ||
| Number of Participants Who Had Uterine Hyperstimulation | Vaginal Misoprostol/Buccal Placebo | 22 | Participants | ||
| Number of Neonatal Intensive Care Unit (NICU) Admission | Buccal Misoprostol/Vaginal Placebo | 30 | participants | ||
| Number of Neonatal Intensive Care Unit (NICU) Admission | Vaginal Misoprostol/Buccal Placebo | 31 | participants | ||
| Number of Doses Misoprostol Used | Buccal Misoprostol/Vaginal Placebo | 3 | Full Range 1 to 7 | doses | |
| Number of Doses Misoprostol Used | Vaginal Misoprostol/Buccal Placebo | 2 | Full Range 1 to 5 | doses | |
| Uterine Rupture | Buccal Misoprostol/Vaginal Placebo | 0 | Participants | ||
| Uterine Rupture | Vaginal Misoprostol/Buccal Placebo | 0 | Participants | ||
| Dose of Oxytocin Used for Augmentation | Buccal Misoprostol/Vaginal Placebo | 6 | Full Range 0 to 30 | milliunits per minute | |
| Dose of Oxytocin Used for Augmentation | Vaginal Misoprostol/Buccal Placebo | 4 | Full Range 0 to 36 | milliunits per minute | |
| Number of Participants With Neonatal Cord Gases Measured | Buccal Misoprostol/Vaginal Placebo | 12 | Participants | ||
| Number of Participants With Neonatal Cord Gases Measured | Vaginal Misoprostol/Buccal Placebo | 15 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02408315/results